Perspectives and challenges of antioxidant therapy for atrial fibrillation.
about
Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality.Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study.COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survivalArrhythmogenic Substrates for Atrial Fibrillation in ObesityNew-onset of postoperative atrial fibrillation is likely to recur in the absence of other triggers
P2860
Perspectives and challenges of antioxidant therapy for atrial fibrillation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Perspectives and challenges of antioxidant therapy for atrial fibrillation.
@en
Perspectives and challenges of antioxidant therapy for atrial fibrillation.
@nl
type
label
Perspectives and challenges of antioxidant therapy for atrial fibrillation.
@en
Perspectives and challenges of antioxidant therapy for atrial fibrillation.
@nl
prefLabel
Perspectives and challenges of antioxidant therapy for atrial fibrillation.
@en
Perspectives and challenges of antioxidant therapy for atrial fibrillation.
@nl
P2093
P2860
P50
P1476
Perspectives and challenges of antioxidant therapy for atrial fibrillation
@en
P2093
Daniel Petrovic
Iveta Gasparova
Martin Caprnda
Miroslava Rabajdova
Peter Kruzliak
Peter Kubatka
Radka Opatrilova
Slavomira Filipova
Vanda Valentova
Vladimir Nosal
P2860
P2888
P356
10.1007/S00210-016-1320-9
P577
2016-11-29T00:00:00Z